期刊文献+

复方甘草酸苷拮抗博莱霉素致大鼠肺纤维化的实验研究 被引量:11

Antagonistic Effect of Compound Glycyrrhizin on Bleomycin-induced Pulmonary Fibrosis of Rats
暂未订购
导出
摘要 目的:观察复方甘草酸苷对模型动物肺纤维化的拮抗作用。方法:在SD大鼠气管内一次性注入博莱霉素A5制备肺纤维化大鼠模型,次日分别给予复方甘草酸苷和醋酸泼尼松龙(对照)治疗,测定、分析各组给药21d后肺组织脏器系数、肺组织病理、肺泡间隔面积、炎细胞面积、积分光密度改变情况。结果:与模型组比较,复方甘草酸苷组肺脏系数有减小趋势,肺组织病理改善,肺泡间隔面积明显减少(P<0.01),炎细胞面积总和、积分光密度显著降低(P<0.001);与醋酸泼尼松龙组比较无明显差异(P>0.05)。结论:复方甘草酸苷有拮抗模型动物肺纤维化的作用。 OBJECTIVE: To observe the antagonistic effect of compound glycyrrhizin on bleomycin A5-induced pulmonary fibrosis of rats, METHODS; Pulmonary fibrosis model was built by injecting bleomycin AS to tracheas of SD rats in one time, the next day, control groups were administered with compound glycyrrhizin and prednisolone acetate, 21 days after administration, organ coefficients, pathology, areas of alveolar septum, areas of the inflammatory cells and the integral pho todensity of the pulmonary tissues were detected and analyzed. RESULTS: As compared with the model group, the compound glycyrrhizin group had a diminished organ coefficient, ameliorated pathological change for pulmonary tissues and reduced areas of alveolar septum (P 〈 0.01), and total area of the inflammatory cells and the integral photodensity decreased significantly (P 〈 0.001), and there was no significant difference as compared with the compound glycyrrhizin group and the prednisolone acetate group (P 〉0.05). CONCLUSION : Compound glycyrrhizin has antagonistic effect on pulmonary fibrosis of model rats.
出处 《中国药房》 CAS CSCD 北大核心 2006年第7期497-499,共3页 China Pharmacy
关键词 复方甘草酸苷 大鼠 拮抗 肺纤维化 Compound glycyrrhizin Rats Antagonism Pulmonary fibrosis
  • 相关文献

参考文献6

二级参考文献20

  • 1王吉耀,刘维田,胡美玉,朱无难,童家琪.甘草酸(强力宁)对成纤维细胞Ⅰ、Ⅲ型前胶原mRNA表达的抑制作用[J].肝脏,1996,1(2):81-83. 被引量:49
  • 2郑继海,卢光洲,王金彩.2001年~2003年河南新乡市8家医院慢性肝病治疗药物利用分析[J].中国药房,2004,15(11):680-681. 被引量:2
  • 3[1]Hiromitsu Kumada.Long- term treatment of chronic hepatitis C with glycyrrhizin[stronger neo- minophagen C(SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma[J]. Oncology, 2002,62,(1):94.
  • 4[2]Ohtsuki K.Separation of phospholipase A2 in Habu snake venom by glycyrrhizin(GL)- affinity column chromatography and identification of a GL- sensitive enzyme[J]. Biol Pharm Bull, 1998,21:574.
  • 5[3]Shimoyama Y.Physiological correlation between glycyrrhizin,glycyrrhizin- binding lipoxygenase and casein kinase Ⅱ [J].FFBS Lett, 1996,391:238.
  • 6[4]Zhang Y.Bidirectional control by glycurrhizin of the growth response of lymphocytes stimulated through a receptor- bypassed pathway[J]. Immunol Lett ,1992,32:147.
  • 7[5]Kimura M.Selective activation of extrathymic T cells in the liver by glycyrrhizin[J]. Biotherapy ,1992,5:167.
  • 8[6]Takahara T,Watanabe A, Shiraki K.Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study[J]. J Hepatol, 1994,21:601.
  • 9[7]Sato H, Goto W, Yamamura J.Therapeutic basis of glycyrrhizin on chronic hepatitis B[J]. Antivir Res,1996,30:171.
  • 10[8]Iino S.Therapeutic effects of stronger neo- minopha_ gen C at different doses on chronic hepatitis and liver cirrhosis[J]. Hepatol Res ,2001,19:31.

共引文献206

同被引文献169

引证文献11

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部